7 October 2020 in Journal of Neurology, Neurosurgery & Psychiatry
Objectives To study the efficacy and safety of bilateral globus pallidus internus deep brain stimulation (GPi-DBS) in refractory Meige syndrome (MS) and evaluate the psychiatric disorders before and after surgery. Methods Twenty-two patients with MS treated with bilateral GPi-DBS were retrospectively analysed before surgery and after continuous neurostimulation. Before surgery, patients were assessed by the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS), Self-Rating Depression Scale, Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36) and Pittsburgh Sleep Quality Index (PQSI), which corresponded to motor symptoms, depressive state, quality of life and sleep quality, respectively. The implantable pulse generator of each patient was activated at 1 month after surgery. At 1 month, 3 months, 6 months and 12 months after continuous neurostimulation, all patients were evaluated by the same scales above. Results The BFMDRS movement scores decreased from 15.0±5.3 before surgery to 3.5±4.5 at 12 months after neurostimulation, with a mean improvement of 78% (p<0.001). The BFMDRS disability scores improved from 7.4±4.9 before surgery to 4.0±4.6 at 12 months after neurostimulation, with a mean improvement of 56% (p<0.001). The postoperative SF-36 scores had the remarkable improvement compared with baseline scores. Impaired sleep quality was found in 82% of patients and depression in 64% before surgery, which didn’t neither obtained amelioration after continuous neurostimulation. Conclusions Bilateral pallidal neurostimulation is a beneficial therapeutic option for refractory MS, which could improve the motor symptoms except for depression and sleep quality.
7 November 2023 in European Journal of Neurology
Background and purpose: Deep brain stimulation (DBS) has emerged as a promising treatment for movement disorders. This prospective study aims to evaluate the effects of bilateral subthalamic nucleus DBS (STN‐DBS) on motor and non‐motor symptoms in patients with primary Meige syndrome.Methods: Thirty patients who underwent bilateral STN‐DBS between April 2017 and June 2020 were included. Standardized and validated scales were utilized to assess the severity of dystonia, health‐related quality of life, sleep, cognitive function and mental status at baseline and at 1 year and 3 years after neurostimulation.Results: The Burke−Fahn−Marsden Dystonia Rating Scale movement scores showed a mean improvement of 63.0% and 66.8% at 1 year and 3 years, respectively, after neurostimulation. Similarly, the Burke−Fahn−Marsden Dystonia Rating Scale disability scores improved by 60.8% and 63.3% at the same time points. Postoperative quality of life demonstrated a significant and sustained improvement throughout the follow‐up period. However, cognitive function, mental status, sleep quality and other neuropsychological functions did not change after 3 years of neurostimulation. Eight adverse events occurred in six patients, but no deaths or permanent sequelae were reported.Conclusions: Bilateral STN‐DBS is a safe and effective alternative treatment for primary Meige syndrome, leading to improvements in motor function and quality of life. Nevertheless, it did not yield significant amelioration in cognitive, mental, sleep status and other neuropsychological functions after 3 years of neurostimulation.
13 September 2024 in Neurological Sciences
19 August 2025 in Neurosurgical Review
13 December 2025 in Annals of Medicine
To investigate the clinical significance of the other Babinski sign in hemifacial spasm (HFS), focusing on its association with symptom severity and specific neurovascular compression (NVC) patterns. This prospective observational study evaluated 69 consecutive HFS patients undergoing microvascular decompression. The association between the other Babinski sign and HSGS scores was assessed using the chi-square test for independence, with Cramer's V quantifying association strength. Subsequently, univariate and multivariate logistic regression analyses were performed to identify NVC patterns predictive of the other Babinski sign. The other Babinski sign was present in 15/69 (21.7%) patients. Its presence was significantly associated with higher HSGS scores (p = 0.011), indicating greater HFS severity (Spearman's rho = 0.355, Cramer's V = 0.434, p = 0.003). Multivariate logistic regression identified the η-like vertebral artery-posterior inferior cerebellar artery (VA-PICA) configuration as a significant independent predictor for the other Babinski sign (Odds Ratio = 4.454, 95% CI: 1.116-17.773, p = 0.034). The other Babinski sign is a significant clinical indicator of more severe HFS and is strongly associated with the η-like VA-PICA compression pattern. This sign may aid in preoperative assessment by predicting HFS severity and specific underlying vascular NVC morphologies, potentially informing surgical strategy.